Literature DB >> 22917637

Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.

Liu Xue1, Shurong Hou, Wenchao Yang, Lei Fang, Fang Zheng, Chang-Guo Zhan.   

Abstract

It can be argued that an ideal anti-cocaine medication would be one that accelerates cocaine metabolism producing biologically inactive metabolites via a route similar to the primary cocaine-metabolizing pathway, i.e., hydrolysis catalyzed by butyrylcholinesterase (BChE) in plasma. However, wild-type BChE has a low catalytic efficiency against naturally occurring (-)-cocaine. Interestingly, wild-type BChE has a much higher catalytic activity against unnatural (+)-cocaine. According to available positron emission tomography (PET) imaging analysis using [(11)C](-)-cocaine and [(11)C](+)-cocaine tracers in human subjects, only [(11)C](-)-cocaine was observed in the brain, whereas no significant [(11)C](+)-cocaine signal was observed in the brain. The available PET data imply that an effective therapeutic enzyme for treatment of cocaine abuse could be an exogenous cocaine-metabolizing enzyme with a catalytic activity against (-)-cocaine comparable to that of wild-type BChE against (+)-cocaine. Our recently designed A199S/F227A/S287G/A328 W/Y332G mutant of human BChE has a considerably improved catalytic efficiency against (-)-cocaine and has been proven active in vivo. In the present study, we have characterized the catalytic activities of wild-type BChE and the A199S/F227A/S287G/A328 W/Y332G mutant against both (+)- and (-)-cocaine at the same time under the same experimental conditions. Based on the obtained kinetic data, the A199S/F227A/S287G/A328 W/Y332G mutant has a similarly high catalytic efficiency (kcat/KM) against (+)- and (-)-cocaine, and indeed has a catalytic efficiency (k(cat/)K(M) = 1.84 × 10(9) M(-1) min(-1)) against (-)-cocaine comparable to that (k(cat)/K(M) = 1.37 × 10(9) M(-1) min(-1)) of wild-type BChE against (+)-cocaine. Thus, the mutant may be used to effectively prevent (-)-cocaine from entering brain and producing physiological effects in the enzyme-based treatment of cocaine abuse.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917637      PMCID: PMC3527670          DOI: 10.1016/j.cbi.2012.08.003

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  39 in total

Review 1.  Neurobiology of butyrylcholinesterase.

Authors:  Sultan Darvesh; David A Hopkins; Changiz Geula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

Review 2.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Addiction as a computational process gone awry.

Authors:  A David Redish
Journal:  Science       Date:  2004-12-10       Impact factor: 47.728

4.  First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine.

Authors:  Chang-Guo Zhan; Shi-Xian Deng; Jaime G Skiba; Beth A Hayes; Sarah M Tschampel; George C Shields; Donald W Landry
Journal:  J Comput Chem       Date:  2005-07-30       Impact factor: 3.376

5.  Activities of the enantiomers of cocaine and some related compounds as substrates and inhibitors of plasma butyrylcholinesterase.

Authors:  S J Gatley
Journal:  Biochem Pharmacol       Date:  1991-04-15       Impact factor: 5.858

Review 6.  Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.

Authors:  D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

Review 7.  Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2009-06       Impact factor: 3.808

Review 8.  Rational design of an enzyme mutant for anti-cocaine therapeutics.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

9.  Reaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (-)-Cocaine.

Authors:  Junjun Liu; Chang-Guo Zhan
Journal:  J Chem Theory Comput       Date:  2012-03-06       Impact factor: 6.006

10.  Rapid stereoselective hydrolysis of (+)-cocaine in baboon plasma prevents its uptake in the brain: implications for behavioral studies.

Authors:  S J Gatley; R R MacGregor; J S Fowler; A P Wolf; S L Dewey; D J Schlyer
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

View more
  9 in total

1.  Free energy profiles of cocaine esterase-cocaine binding process by molecular dynamics and potential of mean force simulations.

Authors:  Yuxin Zhang; Xiaoqin Huang; Keli Han; Fang Zheng; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2016-05-06       Impact factor: 5.192

2.  Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.

Authors:  Natalie E Zlebnik; Stephen Brimijoin; Yang Gao; Amy T Saykao; Robin J Parks; Marilyn E Carroll
Journal:  Neuropsychopharmacology       Date:  2014-01-10       Impact factor: 7.853

3.  Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene.

Authors:  Xirong Zheng; Xiabin Chen; Ting Zhang; Max Zhan; Chang-Guo Zhan; Fang Zheng
Journal:  Org Biomol Chem       Date:  2020-03-11       Impact factor: 3.876

4.  A plant-derived cocaine hydrolase prevents cocaine overdose lethality and attenuates cocaine-induced drug seeking behavior.

Authors:  Katherine E Larrimore; Latha Kannan; R Player Kendle; Tameem Jamal; Matthew Barcus; Kathryn Stefanko; Jacquelyn Kilbourne; Stephen Brimijoin; Chang-Guo Zhan; Janet Neisewander; Tsafrir S Mor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-05-06       Impact factor: 5.067

5.  Long-Term Blockade of Cocaine Self-Administration and Locomotor Activation in Rats by an Adenoviral Vector-Delivered Cocaine Hydrolase.

Authors:  John R Smethells; Natashia Swalve; Stephen Brimijoin; Yang Gao; Robin J Parks; Adam Greer; Marilyn E Carroll
Journal:  J Pharmacol Exp Ther       Date:  2016-03-11       Impact factor: 4.030

6.  Reaction Pathway for Cocaine Hydrolase-Catalyzed Hydrolysis of (+)-Cocaine.

Authors:  Yuan Yao; Junjun Liu; Fang Zheng; Chang-Guo Zhan
Journal:  Theor Chem Acc       Date:  2015-12-28       Impact factor: 1.702

7.  Plant-expressed cocaine hydrolase variants of butyrylcholinesterase exhibit altered allosteric effects of cholinesterase activity and increased inhibitor sensitivity.

Authors:  Katherine E Larrimore; I Can Kazan; Latha Kannan; R Player Kendle; Tameem Jamal; Matthew Barcus; Ashini Bolia; Stephen Brimijoin; Chang-Guo Zhan; S Banu Ozkan; Tsafrir S Mor
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

8.  Genome-edited skin epidermal stem cells protect mice from cocaine-seeking behaviour and cocaine overdose.

Authors:  Yuanyuan Li; Qingyao Kong; Jiping Yue; Xuewen Gou; Ming Xu; Xiaoyang Wu
Journal:  Nat Biomed Eng       Date:  2018-09-17       Impact factor: 25.671

9.  ESTHER, the database of the α/β-hydrolase fold superfamily of proteins: tools to explore diversity of functions.

Authors:  Nicolas Lenfant; Thierry Hotelier; Eric Velluet; Yves Bourne; Pascale Marchot; Arnaud Chatonnet
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.